In lung cancer (Wang et al., 2019), osteosarcoma (Lu et al., 2020) and retinoblastoma (He and Qin, 2020), it has been reported that LEF1-AS1 is an upregulated oncogene promoting tumor progression. Here, LEF1 is linked to lung carcinoma.